AI-HOPE Lung Cancer: Building a Predictive Tool for Metastatic Lung Cancer

NCT06788366 · clinicaltrials.gov ↗

RECRUITING

Status

2000

Enrollment

OTHER

Sponsor class

Conditions

NSCLC Stage IV

Interventions

DRUG: Immunotherapy
DRUG: Chemotherapy

Sponsor

IRCCS San Raffaele